Human intestinal Caco-2 cells display active transport of benzo[a]pyrene metabolites

被引:48
|
作者
Buesen, R
Mock, M
Nau, H
Seidel, S
Jacob, J
Lampen, A
机构
[1] Hannover Sch Vet Med, Dept Food Toxicol, D-30173 Hannover, Germany
[2] Prof Dr Gernot Grimmer Fdn, Biochem Inst Environm Carcinogens, D-22927 Grosshansdorf, Germany
关键词
benzo[a]pyrene; metabolism; active transport; cytochrome P450; Caco-2; cells;
D O I
10.1016/S0009-2797(02)00076-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Epithelial cells of the gastrointestinal tract are challenged by exposure to many potentially toxic agents including the well-known food contaminant benzo[a]pyrene (B[a]P). They are equipped with a variety of Phase 1- and Phase 2-enzymes that are able to metabolize B[a]P. Furthermore, transmembranous ABC-transport proteins are expressed at the apical pole of these cells. The aim of this study was to investigate whether [C-14]B[a]P or products of the metabolism are transported by intestinal cells back into the gut lumen. The intestinal Caco-2 cell line was used as a metabolism and transport model. Experiments with Caco-2 monolayers in the Transwell(TM)-system revealed that radiolabeled substance is transported towards the apical (luminal) region. This transport was characterized as active and increased after induction of cytochromes P450 1A1 and 1B1 by beta-naphthoflavone. On the other hand, transport was decreased with the concomitant inhibition of Phase 1-metabolism. TLC-analysis revealed that the primary metabolites of B[a]P found in the supernatant were very polar; other metabolites of less polarity could only be detected in trace amounts. These results indicate that B[a]P is metabolized by Caco-2 cells to highly polar metabolites resulting from biphasic metabolism and that these polar metabolites are subject to an apically directed transport. Chemical inhibition studies showed that P-glycoprotein and MRP1 or 2 were not involved in this polarized B[a]P-metabolite secretion. (C) 2002 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:201 / 221
页数:21
相关论文
共 50 条
  • [41] Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer
    Sugihara, Narumi
    Toyama, Kumiko
    Michihara, Akihiro
    Akasaki, Kenji
    Tsuji, Hiroshi
    Furuno, Koji
    TOXICOLOGY, 2006, 223 (1-2) : 156 - 165
  • [42] Transepithelial transport of microbial metabolites of quercetin in intestinal Caco-2 cell monolayers
    Konishi, Y
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2005, 53 (03) : 601 - 607
  • [43] Effect of benzo[a]pyrene and flavonoids on the AhR and Nrf2 pathways in Caco-2 cells
    van Liempt, M.
    Roos, P. H.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2011, 383 : 92 - 92
  • [44] Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells
    Walgren, RA
    Walle, UK
    Walle, T
    BIOCHEMICAL PHARMACOLOGY, 1998, 55 (10) : 1721 - 1727
  • [45] TRANSPORT OF ASCORBIC-ACID ACROSS HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
    MOREHOUSE, HF
    KUO, SM
    FASEB JOURNAL, 1995, 9 (04): : A987 - A987
  • [46] NA+-INDEPENDENT LYSINE TRANSPORT IN HUMAN INTESTINAL EPITHELIAL (CACO-2) CELLS
    THWAITES, DT
    MARKOVICH, D
    MURER, H
    SIMMONS, NL
    JOURNAL OF PHYSIOLOGY-LONDON, 1995, 489P : P107 - P108
  • [47] Effects of dietary bioactive polyphenols on iron transport in human intestinal Caco-2 cells
    Kim, Eun-Young
    Ham, Soo-Kyung
    Shigenaga, Mark
    Han, Okhee
    FASEB JOURNAL, 2008, 22
  • [48] Effects of metformin on bile salt transport by monolayers of human intestinal Caco-2 cells
    Carter, D
    Howlett, HCS
    Wiernsperger, NF
    Bailey, C
    DIABETES OBESITY & METABOLISM, 2002, 4 (06): : 424 - 427
  • [49] Comparison between active and passive drug transport in human intestinal epithelial (Caco-2) cells in vitro and human jejunum in vivo
    Lennernas, H
    Palm, K
    Fagerholm, U
    Artursson, P
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 127 (01) : 103 - 107
  • [50] Studies on the intestinal transport of human milk oligosaccharides (HMO) using Caco-2 cells
    Gnoth, MJ
    Rudloff, S
    Kunz, C
    Kinne, RKH
    FOOD RESEARCH INTERNATIONAL, 2002, 35 (2-3) : 145 - 149